Auris Medical Holding's (EARS) Keyzilen Granted FDA Fast Track Designation in AP Tinnitus
Tweet Send to a Friend
Auris Medical Holding AG (Nasdaq: EARS) announced that the US Food and Drug Administration (FDA) has granted fast track designation ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
